Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck

Showing 15 posts of 363 posts found.

Codexis and Merck develop green Victrelis production

April 10, 2012
Manufacturing and Production Codexis, Merck, manufacturing

Merck has teamed up with catalyst specialist Codexis to develop a more efficient manufacturing process for recently-approved hepatitis C treatment …

News
Novo Nordisk HQ

Victoza superiority to Januvia made official by FDA

April 10, 2012
Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes

Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …

News
michael_holston-1-3001

Merck appoints new chief ethics and compliance officer

March 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck

Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …

Appointment
a_mahmoud

Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud

March 29, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines

Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors.  Mahmoud, a global infectious …

Appointment
Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012
Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …

News
Merck image

Merck ends development on atrial fibrillation pill

March 20, 2012
Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation

Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …

News
Merck image

Merck warned over missing Januvia safety study

March 13, 2012
Research and Development FDA, Januvia, Merck, study

Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …

News
mark_archer_013

inVentiv appoints former Quintiles man Mark Archer

March 9, 2012
Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv

Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …

Appointment
Victrelis picture

NICE recommends Victrelis in speedy review

March 9, 2012
Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis

NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review.  In its final …

News

Merck’s eye drug Zioptan gains FDA approval

February 14, 2012
Sales and Marketing Merck, Pfizer, Xalatan, Zioptan

The FDA has approved Merck’s eye solution Zioptan to treat a common eye condition. Zioptan (tafluprost ophthalmic solution) can now …

News

Fate of Merck’s vorapaxar still unclear

February 8, 2012
Medical Communications, Sales and Marketing Merck, vorapaxar

Merck & Co’s blood thinner vorapaxar, designed to prevent blood clots and reduce heart attacks, is still causing bleeding in …

News

Merck prepares insomnia candidate

February 7, 2012
Sales and Marketing Merck, insomnia

Merck is to file its new insomnia drug suvorexant, with US regulators later this year. Suvorexant is an orexin receptor …

News
Merck image

Merck posts strong results for 2011

February 2, 2012
Sales and Marketing Frazier, Merck, Singulair, Victrelis

Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011.  The US firm …

News
Vioxx image

Merck pays $37m to settle Canadian Vioxx claims

January 23, 2012
Sales and Marketing Canada, Merck, Vioxx

Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada.  The settlement …

News

Merck facility reborn as science park

January 11, 2012
Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland

A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026